Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions
Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the single-dose relative bioavailability of
Ranbaxy and Ortho-McNeil Pharmaceutical (Topamax®) 25 mg topiramate tablets following a 50 mg
dose under fasting conditions.